Hims & Hers Narrows 2026 Revenue Guidance Amid Margin Pressures

Key Facts

Hims & Hers narrowed its 2026 revenue guidance as the company faces contracting profit margins. Reuters reported that the healthcare provider updated its full-year outlook while managing ongoing pressure on its profitability levels.

The adjustment comes as the company manages costs and operational shifts potentially linked to its recent expansion into GLP-1 weight-loss drug distribution. Shares of Hims & Hers have faced a mixed outlook as investors weigh the narrowed revenue range against the reported margin contraction.